Got this in my e-mail today...
The Rabies Challenge Fund is pleased to announce that the canine rabies
studies have begun!!! Permission is granted to post and cross-post the text
of our press
Regards, Kris L. Christine
The Rabies Challenge Fund
CANINE RABIES CHALLENGE STUDIES BEGIN !
One of the most important vaccine research studies in veterinary medicine is
underway at the University of Wisconsin School of Veterinary Medicine in
Madison. Dr. Ronald Schultz, a leading authority on veterinary vaccines and
Chair of the Department of
Pathobiological Sciences, has begun concurrent 5 and 7 year challenge studies to
determine the long-term duration of immunity of the canine rabies vaccine, with
the goal of extending the state-mandated interval for boosters. These will be
the first long-term challenge studies on the canine rabies vaccine to be
published in the
Dr. Schultz comments that: "We are all very excited to start this study that
demonstrate that rabies vaccines can provide a minimum of 7 years of immunity."
This research is being financed by The Rabies Challenge Fund, a charitable
founded by pet vaccine disclosure advocate Kris L. Christine of Maine, who
serves as Co-Trustee with world-renowned veterinary research scientist and
practicing clinician, Dr. W. Jean Dodds of Hemopet in California. The Rabies
Challenge Fund recently met its goal of $177,000 to fund the studies' first year
budget with contributions from dog owners, canine groups, trainers,
veterinarians, and small businesses. Annual budget goals of $150,000 for the
studies must be met in the future.
Dr. Jean Dodds, DVM states: "This is the first time in my 43 years of
veterinary issues that what started as a grass-roots effort to change an
regulation affecting animals will be addressed scientifically by an acknowledged
benefit all canines in the future."
Scientific data published in 1992 by Michel Aubert and his research team
demonstrated that dogs were immune to a rabies challenge 5 years after
vaccination, while Dr. Schultz's
serological studies documented antibody titer counts at levels known to confer
rabies 7 years post-vaccination. This data strongly suggests that state laws
annual or triennial rabies boosters for dogs are redundant. Because the rabies
vaccine is the most potent of the veterinary vaccines and associated with
significant adverse reactions, it should not be given more often than is
necessary to maintain immunity. Adverse
reactions such autoimmune diseases affecting the thyroid, joints, blood, eyes,
skin, kidney, liver, bowel and central nervous system; anaphylactic shock;
aggression; seizures; epilepsy; and fibrosarcomas at injection sites are linked
to rabies vaccinations.
Study co-trustee Kris Christine adds: "Because the USDA does not require vaccine
manufacturers to provide long-term duration of immunity studies documenting
maximum effectiveness when licensing their products, concerned dog owners have
contributed the money to fund this research themselves. We want to ensure that
rabies immunization laws are based upon independent, long-term scientific data."
More information and regular updates on The Rabies Challenge Fund and the
5 and 7 year challenge studies it is financing can be found at the fund's
website designed by volunteer Andrea Brin at: